17β-estradiol inhibits endothelin-1 production and attenuates cerebral vasospasm after experimental subarachnoid hemorrhage

Experimental Biology and Medicine

Volumn 231, Issue 6, 2006, Pages 1054-1057

  Lin, Chih Lung ^a   Dumont, Aaron S ^b   Wu, Shu Chuan ^a   Wang, Chih Jen ^a   Howng, Sheng Long ^a   Huang, Yan Fen ^a   Wong, Wee Yen ^a   Kassell, Neal F ^b   Jeng, Arco Y ^c   Kwan, Aij Lie ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b UNIVERSITY OF VIRGINIA   (United States)

^c NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Endothelin 1; Estrogen; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

DRUG VEHICLE; ENDOTHELIN 1; ESTRADIOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BASILAR ARTERY; BLOOD SAMPLING; BRAIN VASOSPASM; CONFERENCE PAPER; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; MALE; NEUROPROTECTION; NONHUMAN; RAT; SUBARACHNOID HEMORRHAGE; ANIMAL; ARTICLE; COMPARATIVE STUDY; DISEASE MODEL; DRUG ANTAGONISM; INTRACRANIAL ANEURYSM; RANDOMIZATION; SPRAGUE DAWLEY RAT;

ANIMALIA; ZEA MAYS;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; ESTRADIOL; INTRACRANIAL ANEURYSM; MALE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 33744923675     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Kassell NF, Sasaki T, Colohan AR, Nazar, G.. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 16:562-572, 1985.
2. Lin CL, Jeng AY, Howng SL, Kwan AL. Endothelin and subarachnoid hemorrhage-induced cerebral vasospasm: pathogenesis and treatment. Curr Med Chem 11:1779-1791, 2004.
3. Suzuki H, Sato S, Suzuki Y, Takekoshi K, Ishihara N, Shimoda S. Increased endothelin concentration in CSF from patients with subarachnoid hemorrhage. Acta Neurol Scand 81:553-554, 1990.
4. Mascia L, Fedorko L, Stewart DJ, Mohamed F, terBrugge K, Ranieri VM, Wallace MC. Temporal relationship between endothelin-1 concentrations and cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. Stroke 32:1185-1190, 2001.
5. Tostes RC, Nigro D, Fortes ZB, Carvalho MH. Effects of estrogen on the vascular system. Braz J Med Biol Res 36:1143-1158, 2003.
6. Hong HJ, Liu JC, Chan P, Juan SH, Loh SH, Lin JG, Cheng TH. 17beta-estradiol down regulates angiotensin-II-induced endothelin-1 gene expression in rat aortic smooth muscle cells. J Biomed Sci 11:27-36, 2004.
7. Anwaar I, Rendell M, Gottsater A, Lindgarde F, Hulthen UL, Mattiasson I. Hormone replacement therapy in healthy postmenopausal women. Effects on intraplatelet cyclic guanosine monophosphate, plasma endothelin-1 and neopterin. J Intern Med 247:463-470, 2000.
8. Juvela S. Plasma endothelin and big endothelin concentrations and serum endothelin-converting enzyme activity following aneurysmal subarachnoid hemorrhage. Neurosurgery 97:1287-1293, 2002.
9. Menon DK, Day D, Kuc RE, Downie AJ, Chatfield DA, Davenport AP. Arteriojugular endothelin-1 gradients in aneurysmal subarachnoid haemorrhage. Clin Sci (Lond) 103(Suppl 48):S399-S403, 2002.
10. Mima T, Yanagisawa M, Shigeno T, Saito A, Goto K, Takakura K, Masaki T. Endothelin acts in feline and canine cerebral arteries from the adventitial side. Stroke 20:1553-1556, 1989.
11. Clozel M, Breu V, Burri K, Cassal JM, Fischli W, Gray GA, Hirth G, Loffler BM, Muller M, Neidhart W, Ramuz H. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature 365:759-761, 1993.
12. Hamann G, Isenberg E, Strittmatter M, Schimrigk K. Absence of elevation of big endothelin in subarachnoid hemorrhage. Stroke 24:383-386, 1993.
13. Nishizawa S, Chen D, Yokoyama T, Yokota N, Otha S. Endothelin-1 initiates the development of vasospasm after subarachnoid haemorrhage through protein kinase C activation, but does not contribute to prolonged vasospasm. Acta Neurochir (Wien) 142:1409-1415, 2000.
14. Davis P. Stroke in women. Curr Opin Neurol 7:36-40, 1994.
15. Wang Q, Santizo R, Baughman VL, Pelligrino DA, Iadecola C. Estrogen provides neuroprotection in transient forebrain ischemia through perfusion-independent mechanisms in rats. Stroke 30:630-637, 1990.
16. Dubey RK, Jackson EK. Cardiovascular protective effects of 17beta-estradiol metabolites. J Appl Physiol 91:1868-1883, 2001.
17. Barton M. Postmenopausal oestrogen replacement therapy and atherosclerosis: can current compounds provide cardiovascular protection? Expert Opin Investig Drugs 10:789-809, 2001.
18. Morey AK, Razandi M, Pedram A, Hu RM, Prins BA, Levin ER. Oestrogen and progesterone inhibit the stimulated production of endothelin-1. Biochem J 330:1097-1105, 1998.
19. Akishita M, Ouchi Y, Miyoshi H, Orimo A, Kozaki K, Eto M, Ishikawa M, Kim S, Toba K, Orimo H. Estrogen inhibits endothelin-1 production and c-fos gene expression in rat aorta. Atherosclerosis 125:27-38, 1996.
20. Chao HH, Chen JJ, Chen CH, Lin H, Cheng CF, Lian WS, Chen YL, Juan SH, Liu JC, Liou JY, Chan P, Cheng TH. Inhibition of angiotensin II induced endothelin-1 gene expression by 17-beta-oestradiol in rat cardiac fibroblasts. Heart 91:664-669, 2005.
21. Saitta A, Altavilla D, Cucinotta D, Morabito N, Frisina N, Corrado F, D'Anna R, Lasco A, Squadrito G, Gaudio A, Cancellieri F, Arcoraci V, Squadrito F. Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women. Arterioscler Thromb Vasc Biol 21:1512-1519, 2001.
22. Yang S-H, He Z, Wu SS, He Y-J, Cutright J, Millard WJ, Day AL, Simpkins JW. 17-b estradiol can reduce secondary ischemic damage and mortality of subarachnoid hemorrhage. J Cereb Blood Flow Metab 21:174-181, 2001.